Dissecting the immune component of neurologic disorders: A grand challenge for the 21st century

Frontiers in Neurology

Volumn JUN, Issue , 2011, Pages

  Coyle, Patricia Katherine ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81755165476     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2011.00037     Document Type: Article

References (8)

1. Fujihara, K. (2011). Neuromyelitis optica and astrocytic damage in its pathogenesis. J. Neurol. Sci. [Epub ahead of print].
2. Greenlee, J. E. (2010). Treatment of paraneoplastic neurologic disorders. Curr. Treat. Options Neurol. 12, 212-230.
3. Idiman, E., and Ozakbas, S. (2011). The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis. Expert Rev. Neurother. 11, 451-462.
4. Mocellin, R., Walterfang, M., and Velakoulis, D. (2007). Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 21, 799-811.
5. Molina-Holgado, E., and Molina-Holgado, F. (2010). Mending the broken brain: neuroimmune interactions in neurogenesis. J. Neurochem. 114, 1277-1290.
6. Ortor, S. M., Wald, L. Confavreux, C., Vukusic S, Krohn, J. P., Ramagopalan, S. V., Herrera, B. M., Sadovnick, A. D., and Ebers, G. C. (2011). Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 76, 425-431.
7. Rosenfeld M. R., and Dalmau J. (2011). Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr. Treat. Options Neurol. 13, 324-332.
8. Wang, J. H., Pappas, D., De Jager, P. K., Pelletier, D., de Bakker, P. I., Kappos, L., Polman, C. H., Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik, L. B., Hafler, D. A., Matthews, P. M., Hauser, S. L., Baranzini, S. E., and Oksenberg, J. R. (2011). Modeling the cumulative genetic risk for multiple sclerosis from genome wide association data. Genome Med. 3, 3.